Position in LQDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$717
New position
Shares Held
9
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#323
of 333 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ankerstar Wealth, LLC holds $5,003 across 11 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
26 | $1,362 | |
| 2 | LQDA |
Liquidia Corp
This page
|
9 | $717 | |
| 3 | PRGO |
PERRIGO Co plc
|
55 | $571 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
11 | $511 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
6 | $496 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
9 | $369 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
12 | $304 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
8 | $289 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $717 | 9 | Shares | Other | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||